216 related articles for article (PubMed ID: 33949761)
1. Serum exosomal lncRNA XIST is a potential non-invasive biomarker to diagnose recurrence of triple-negative breast cancer.
Lan F; Zhang X; Li H; Yue X; Sun Q
J Cell Mol Med; 2021 Aug; 25(16):7602-7607. PubMed ID: 33949761
[TBL] [Abstract][Full Text] [Related]
2. Serum lncRNA TINCR Serve as a Novel Biomarker for Predicting the Prognosis in Triple-Negative Breast Cancer.
Wang X; Li S; Xiao H; Deng X
Technol Cancer Res Treat; 2020; 19():1533033820965574. PubMed ID: 33084530
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer.
Na-Er A; Xu YY; Liu YH; Gan YJ
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):154-160. PubMed ID: 33506903
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
Fan CN; Ma L; Liu N
J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
[TBL] [Abstract][Full Text] [Related]
5. Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis.
Chaudhary P; Gibbs LD; Maji S; Lewis CM; Suzuki S; Vishwanatha JK
Breast Cancer Res; 2020 Jan; 22(1):11. PubMed ID: 31992335
[TBL] [Abstract][Full Text] [Related]
6. Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Bladder Cancer Diagnosis and Prognosis.
Wang J; Yang K; Yuan W; Gao Z
Med Sci Monit; 2018 Dec; 24():9307-9316. PubMed ID: 30576305
[TBL] [Abstract][Full Text] [Related]
7. LncRNA HAND2-AS1 suppressed the growth of triple negative breast cancer via reducing secretion of MSCs derived exosomal miR-106a-5p.
Xing L; Tang X; Wu K; Huang X; Yi Y; Huan J
Aging (Albany NY); 2020 Dec; 13(1):424-436. PubMed ID: 33290256
[TBL] [Abstract][Full Text] [Related]
8. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer.
Tantai J; Hu D; Yang Y; Geng J
Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353
[TBL] [Abstract][Full Text] [Related]
9. A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.
Kleivi Sahlberg K; Bottai G; Naume B; Burwinkel B; Calin GA; Børresen-Dale AL; Santarpia L
Clin Cancer Res; 2015 Mar; 21(5):1207-14. PubMed ID: 25547678
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNAs in triple-negative breast cancer: A new frontier in the regulation of tumorigenesis.
Thakur KK; Kumar A; Banik K; Verma E; Khatoon E; Harsha C; Sethi G; Gupta SC; Kunnumakkara AB
J Cell Physiol; 2021 Dec; 236(12):7938-7965. PubMed ID: 34105151
[TBL] [Abstract][Full Text] [Related]
11. A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer.
Wu J; Cai Y; Zhao G; Li M
J Clin Lab Anal; 2021 Jun; 35(6):e23779. PubMed ID: 33934391
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum exosomal LncRNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer.
Zhang S; Du L; Wang L; Jiang X; Zhan Y; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Shi Y; Wang C
J Cell Mol Med; 2019 Feb; 23(2):1396-1405. PubMed ID: 30467945
[TBL] [Abstract][Full Text] [Related]
13. The long non-coding RNA landscape in triple-negative breast cancer.
Zhang W; Guan X; Tang J
Cell Prolif; 2021 Feb; 54(2):e12966. PubMed ID: 33314471
[TBL] [Abstract][Full Text] [Related]
14. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling.
Zheng S; Li M; Miao K; Xu H
J Cell Biochem; 2020 Mar; 121(3):2225-2235. PubMed ID: 31692053
[TBL] [Abstract][Full Text] [Related]
15. A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers.
Liu M; Xing LQ; Liu YJ
Medicine (Baltimore); 2017 Mar; 96(9):e6222. PubMed ID: 28248879
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Transcriptome Profiling Reveals Multigene Signatures in Triple-Negative Breast Cancer.
Liu YR; Jiang YZ; Xu XE; Hu X; Yu KD; Shao ZM
Clin Cancer Res; 2016 Apr; 22(7):1653-62. PubMed ID: 26813360
[TBL] [Abstract][Full Text] [Related]
17. A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.
Wang PS; Chou CH; Lin CH; Yao YC; Cheng HC; Li HY; Chuang YC; Yang CN; Ger LP; Chen YC; Lin FC; Shen TL; Hsiao M; Lu PJ
Oncogene; 2018 Aug; 37(34):4662-4678. PubMed ID: 29755127
[TBL] [Abstract][Full Text] [Related]
18. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
Liu T; Zhang X; Gao S; Jing F; Yang Y; Du L; Zheng G; Li P; Li C; Wang C
Oncotarget; 2016 Dec; 7(51):85551-85563. PubMed ID: 27888803
[TBL] [Abstract][Full Text] [Related]
19. LncRNA TCONS_l2_00002973 correlates with less advanced tumor stage and favorable survival, and also inhibits cancer cells proliferation while enhancing apoptosis in triple-negative breast cancer.
Yan J; Wang R; Wu Z
J BUON; 2019; 24(2):535-542. PubMed ID: 31128002
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNAs (lncRNAs) in triple negative breast cancer.
Wang Q; Gao S; Li H; Lv M; Lu C
J Cell Physiol; 2017 Dec; 232(12):3226-3233. PubMed ID: 28138992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
